| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/16/2004 | WO2004012499A3 Method of selecting cells for somatic cell nuclear transfer |
| 09/16/2004 | WO2004011938B1 Method and device for screening molecules in cells |
| 09/16/2004 | WO2003106658A3 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
| 09/16/2004 | WO2003102160A3 Rationally designed polysaccharide lyases derived from chondroitinase b |
| 09/16/2004 | WO2003100012A3 Microarrays and method for running hybridization reaction for multiple samples on a single microarray |
| 09/16/2004 | WO2003099999A3 Generation and selection of protein library in silico |
| 09/16/2004 | WO2003096974A3 ORIENTIA TSUTSUGAMUSHI TRUNCATED RECOMBINANT OUTER MENBRANE PROTEIN (r47) AND (r56) VACCINES DIAGNOSTICS AND THERAPEUTICS FOR SCRUB TYPHUS AND HIV INFECTION |
| 09/16/2004 | WO2003095615A3 Transgenic plants with a suppressed triterpene level |
| 09/16/2004 | WO2003089901A3 Methods for preparing libraries of unique tags and related screening methods |
| 09/16/2004 | WO2003089603A3 Cytokine receptor |
| 09/16/2004 | WO2003088898A3 Compositions and methods for the diagnosis and treatment of tumor |
| 09/16/2004 | WO2003074657A3 Cold shock inducible expression and production of heterologous polypeptides |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |
| 09/16/2004 | WO2003050244A3 Antisense modulation of g protein-coupled receptor etbr-lp-2 expression |
| 09/16/2004 | WO2003046130A3 Methods for the identification of inhibitors of alpha-aminoadipate reductase and homocitrate synthase as antibiotics |
| 09/16/2004 | WO2003045318A3 Manipulation of cytokine levels using cd83 gene products |
| 09/16/2004 | WO2003040307A3 Heteromultimeric tnf ligand family members |
| 09/16/2004 | WO2003040168A3 Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype |
| 09/16/2004 | WO2003026690A9 Incapacitated whole-cell immunogenic bacterial compositions |
| 09/16/2004 | WO2003018744A3 Transgenic mammal capable of facilitating production of donor-specific functional immunity |
| 09/16/2004 | WO2003014368A3 Use of xylene monooxygenase for the oxidation of substituted monocyclic aromatic compounds |
| 09/16/2004 | WO2003013227A3 Yield-related polynucleotides and polypeptides in plants |
| 09/16/2004 | WO2003008436A3 Methods for the identification of peptidyl compounds interacting with extracellular target molecules |
| 09/16/2004 | WO2002100827A3 Method for increasing the survival of dopamine secreting cells |
| 09/16/2004 | WO2002099043A8 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 09/16/2004 | WO2002092002A3 Screening, diagnostic and therapeutic methods relating to riz |
| 09/16/2004 | WO2002090492A3 Fungal chitinases, polynucleotide sequences encoding same, promoters of same, and uses thereof |
| 09/16/2004 | WO2002077170A3 Expansin protein and polynucleotides and methods of use |
| 09/16/2004 | US20040181829 for mitogen-activated protein kinase kinase kinase (MAPKKK) in mono/dicotyledons; genetic engineering |
| 09/16/2004 | US20040181828 Plant genes encoding DR1 and DRAP1, a global repressor complex of transcription |
| 09/16/2004 | US20040181827 Plant Gntl sequences and the use thereof for the production of plants having reduced or lacking N-acetyl glucosaminyl transferase I (GnTI) activity |
| 09/16/2004 | US20040181826 for for producing flavonoids using transgenic plants transformed by a genetically engineered vector |
| 09/16/2004 | US20040181825 Prevention of Bt resistance development |
| 09/16/2004 | US20040181824 for modulating, in a transgenic plant, expression of the nucleic acids and for increasing transformation efficiency; genetic engineering |
| 09/16/2004 | US20040181821 expression cassettes, efficiently introduced into cultured mammalian cells; allows user to evaluate the transfection and siRNA synthetic efficiency |
| 09/16/2004 | US20040181820 Nucleic acids for transforming fish cells and methods for their use |
| 09/16/2004 | US20040181143 Imaging of a region in a scattering medium |
| 09/16/2004 | US20040181050 Sample processing device and sample processing method |
| 09/16/2004 | US20040181049 from cell or tissue samples, including epithelial cells, fibroblasts, bone marrow progenitors or brain tissue without pretreatment and lysis of red blood cells present in the mixture |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040181042 Antibody recognizing GM1 ganglioside-bound amyloid beta-protein and DNA encoding the antibody |
| 09/16/2004 | US20040181040 Mammalian cytokine-like polypeptide-10 |
| 09/16/2004 | US20040181039 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 09/16/2004 | US20040181037 Phosphatidyl serine receptors and uses thereof |
| 09/16/2004 | US20040181036 Mutant forms of cholera holotoxin as an adjuvant |
| 09/16/2004 | US20040181034 Multimeric Apo A-I agonist compounds |
| 09/16/2004 | US20040181033 Binding agents which inhibit myostatin |
| 09/16/2004 | US20040180848 Method of killing cancer cells |
| 09/16/2004 | US20040180847 Inhibiting synthesis and function; arresting cellular proliferation |
| 09/16/2004 | US20040180844 Method of killing cancer cells |
| 09/16/2004 | US20040180826 Novel receptor that causes cell death |
| 09/16/2004 | US20040180825 Semaphorin polypeptides |
| 09/16/2004 | US20040180819 Characterization of a membrane estrogen receptor |
| 09/16/2004 | US20040180445 Methods and compositions for purification of nucleic acid from a host cell |
| 09/16/2004 | US20040180443 Methods for transfer of DNA segments |
| 09/16/2004 | US20040180442 Low pressure gas accelerated gene gun |
| 09/16/2004 | US20040180440 Modified AAV |
| 09/16/2004 | US20040180439 Expression vector comprising promoter elements and which codes complimentary nucleotide sequences of preferential genes for use as therapeutic tool in targeted tissue/cell therapy; gene expression inhibition |
| 09/16/2004 | US20040180438 Methods and compositions for silencing genes without inducing toxicity |
| 09/16/2004 | US20040180437 Optoinjection methods |
| 09/16/2004 | US20040180433 Methods of using mammalian RNase H and compositions thereof |
| 09/16/2004 | US20040180432 Propagating human hematopoietic cells in culture via inoculation of bioreactor nutrient broth with transgenic stromal cells expressing growth factor proteins and perfusion of progenitor cells with medium with subsequent recovery of hematopoietic tissue |
| 09/16/2004 | US20040180429 Spliceosome mediated RNA trans-splicing in stem cells |
| 09/16/2004 | US20040180428 Automated apparatus for injecting sample of gene, pigment, protein, peptide or drug into oocytes of frogs using pipette-like needle; tissue engineering |
| 09/16/2004 | US20040180423 High density growth of T7 expression strains with auto-induction option |
| 09/16/2004 | US20040180422 Generating phage particles comprising heterologous coat proteins for use as tools in screening and identifying preferential protein ligands; drug screening |
| 09/16/2004 | US20040180416 Comprises nucleotide sequences coding serine-threonine and/or carbon catabolite depressing kinases for use in nutraceuticals and treating metabolic disorders; pharmacogenomics |
| 09/16/2004 | US20040180415 Isolating fusion protein comprised of metal affinity peptide using immobilized metal ion affinity chromatography (IMAC) |
| 09/16/2004 | US20040180413 Method for producing ascorbic acid intermediates |
| 09/16/2004 | US20040180412 Evolving new molecular function |
| 09/16/2004 | US20040180410 Expression vector coding camel proteolytic enzyme for expression in milk products; food processing and cheese manufacturing |
| 09/16/2004 | US20040180407 Novel G protein coupled receptor protein, DNA and its ligand |
| 09/16/2004 | US20040180406 Nucleic acids encoding sialytransferases from C. jejuni |
| 09/16/2004 | US20040180403 Novel 33 phage vectors |
| 09/16/2004 | US20040180396 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 09/16/2004 | US20040180395 Method for detecting calpain3 activity in a biological sample and peptides for implementing said method |
| 09/16/2004 | US20040180386 Using major histocompatibility complex polypeptides as tools in identifying lymphocyte binding sites; immunosuppression and tumor therapeutics |
| 09/16/2004 | US20040180382 for transforming yeast and expressing heterologous polypeptides; genetic engineering and translation analysis |
| 09/16/2004 | US20040180375 AGS proteins and nucleic acid molecules and uses therefor |
| 09/16/2004 | US20040180374 Partial homologous recombination of DNA chain |
| 09/16/2004 | US20040180373 Vector comprising nucleotide sequences coding insecticidal polypeptide for transformation, characterization and propagation of insect resistant plants |
| 09/16/2004 | US20040180371 Nucleotide sequences coding novel serine protease for identifying modulator for diagnosis, treatment and prevention of cell proliferative disorders |
| 09/16/2004 | US20040180366 Comprises nucleotide sequence probes which flank chromosomal breakpoint for identifying genomic translocations; tumor diagnosis |
| 09/16/2004 | US20040180360 Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same |
| 09/16/2004 | US20040180357 Compositions and methods for siRNA inhibition of HIF-1 alpha |
| 09/16/2004 | US20040180356 Comprises nucleotide sequences coding membrane proteins for use in diagnosis, prevention and treatment of cell proliferative, metabolic and inflammatory disorders |
| 09/16/2004 | US20040180354 Comprises polypeptides which are displayable on antigen presenting cells of immune system for use in prevention and treatment of infection and vaccine development; immunotherapy |
| 09/16/2004 | US20040180352 Stabilizing composition for using heterodulpex DNA to generate genetic variation; in vitro reassertion of mutation among related polynucleotides; allelic variation |
| 09/16/2004 | US20040180351 Interfering RNA molecules |
| 09/16/2004 | US20040180350 Methods of creating genetic diversity |
| 09/16/2004 | US20040180348 Method for surface display of proteins of genetic carriers |
| 09/16/2004 | US20040180340 Method for creating polynucleotide and polypeptide sequences |
| 09/16/2004 | US20040180338 Mutated eukariotic transalation initiation factor 2 alpha kinase3, eif2ak3, in patients with neonatal insuluin-dependant diabetes and multiple epiphyseal dyslapsia (wolcott-rallison syndrome) |
| 09/16/2004 | US20040180337 Human extracellular signal regulated kinases |
| 09/16/2004 | US20040180336 Method for enrichment of natural antisense messenger RNA |
| 09/16/2004 | US20040180335 Comprises nucleotide sequences coding transmembrane protein for diagnosis and treatment of epileptic, autoimmune and nervous system disorders |
| 09/16/2004 | US20040180333 Self-replicating RNA molecule from hepatitis C virus |
| 09/16/2004 | US20040180331 Using nucleotide sequences to detect viral infections associated with lympho-proliferative disorders; diagnostic assay |
| 09/16/2004 | US20040180325 Adjustable sensitivity, genetic molecular interaction systems, including protein-protein interaction systems for detection and analysis |
| 09/16/2004 | US20040180058 Vaccine compositions and methods |